In this randomized clinical trial of adults with type 2 diabetes (T2D), the artificial intelligence-based insulin clinical ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a ...

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

For people living with type 1 diabetes or those with severe insulin deficiency, life depends on daily injections of insulin. While insulin therapy has saved millions of lives, it’s far from perfect.